Assessing the Frequencies of Micro- and Macrovascular Complications in Diabetes

被引：0
|
作者：
Esteban Fernandez-Garate, Jose [1 ]
Manuel-Apolinar, Leticia [2 ]
Basurto Acevedo, Maria de Lourdes [2 ]
Zurita-Cruz, Jessie N. [3 ]
Arellano Flores, Maria Luisa [2 ]
Correa Gonzalez, Roberto Alejandro [2 ]
Gonzalez Cisneros, Nelly [1 ]
机构：
[1] Inst Mexicano Seguro Social, Epidemiol Surveillance Coordinat, Mexico City, DF, Mexico
[2] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Endocrine Res Unit, Mexico City, DF, Mexico
[3] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Pediat Hosp, Unit Res Med Nutr, Mexico City, DF, Mexico
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 2021年 / 116卷
关键词：
Type 2 diabetes mellitus; Comorbidities; Epidemiology; Acute complication; Chronic complications; Risk factors; Vascular;
D O I：
10.1016/j.metabol.2020.154471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0004
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [21] Calpain-10 gene polymorphisms in type 2 diabetes and its micro- and macrovascular complications
    Buraczynska, Monika
    Wacinski, Piotr
    Stec, Anna
    Kuczmaszewska, Agata
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (01) : 54 - 58
  • [22] Effect of a fixed combination of perindopril and indapamide on the micro- and macrovascular complications in type-2-diabetes
    Pavlicek, V.
    [J]. DIABETOLOGE, 2008, 4 (01): : 41 - 41
  • [23] Relationship Between Glycaemic Burden and Micro- and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus
    Overbeek, Jetty A.
    van Wijngaarden, Rients P. T.
    Diels, Joris
    Schubert, Agata
    Straatman, Huub
    Besson, Herve
    Steyerberg, Ewout W.
    Hemels, Michiel
    Nijpels, Giel
    Herings, Ron M. C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 462 - 463
  • [24] Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
    Boussageon, R.
    Gueyffier, F.
    Cornu, C.
    [J]. DIABETES & METABOLISM, 2014, 40 (03) : 169 - 175
  • [25] Increased sVCAM-1 levels are associated with micro- and macrovascular complications in type 1 diabetes
    Soedamah-Muthu, SS
    Chaturvedi, N
    Schalkwijk, CG
    Fuller, JH
    Stehouwer, CDA
    [J]. DIABETES, 2001, 50 : A167 - A167
  • [26] Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study
    Schallmoser, Simon
    Zueger, Thomas
    Kraus, Mathias
    Saar-Tsechansky, Maytal
    Stettler, Christoph
    Feuerriegel, Stefan
    [J]. JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [27] Micro- and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland
    Pedersen, Michael Lynge
    Jacobsen, Jytte Lindskov
    Lynge, Anna Rask
    [J]. INTERNATIONAL JOURNAL OF CIRCUMPOLAR HEALTH, 2010, 69 (02) : 195 - 207
  • [28] Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
    Grauslund, Jakob
    Rasmussen, Lars M.
    Green, Anders
    Sjolie, Anne K.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2010, 70 (03): : 188 - 193
  • [29] Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes
    Mesa, Alex
    Gimenez, Marga
    Pueyo, Irene
    Perea, Veronica
    Vinals, Clara
    Blanco, Jesus
    Vinagre, Irene
    Seres-Noriega, Tonet
    Boswell, Laura
    Esmatjes, Enric
    Conget, Ignacio
    Amor, Antonio J.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 189
  • [30] Micro- and macrovascular complications and hyperhomocysteinaemia in type 1 diabetic patients
    Buysschaert, M
    Jamart, J
    Dramais, AS
    Wallemacq, P
    Hermans, MP
    [J]. DIABETES & METABOLISM, 2001, 27 (06) : 655 - 659
12345